SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-083236
Filing Date
2013-11-12
Accepted
2013-11-12 07:49:33
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19541_110q.htm 10-Q 961564
2 EX-31.1.1 a13-19541_1ex31d1d1.htm EX-31.1.1 12295
3 EX-31.2.1 a13-19541_1ex31d2d1.htm EX-31.2.1 12390
4 EX-32.1 a13-19541_1ex32d1.htm EX-32.1 7012
  Complete submission text file 0001104659-13-083236.txt   8206578

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT osir-20130930.xml EX-101.INS 1177959
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20130930.xsd EX-101.SCH 75337
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20130930_cal.xml EX-101.CAL 73250
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20130930_def.xml EX-101.DEF 295534
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20130930_lab.xml EX-101.LAB 1155352
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20130930_pre.xml EX-101.PRE 558158
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 131206995
SIC: 2836 Biological Products, (No Diagnostic Substances)